Print

Print


We struck the same concerns when transitioning to an Abbott track system
from manual analyser workstations. Staff did not believe that lipaemic
samples were being managed as well as the previous manual visual
identification protocols. Regardless of the known impact of turbidity
and water fraction displacement of the chylomicron fractions when we
reviewed all the results from manual reruns of clarified samples
performed by the staff to those of the results performed on the track
under the Abbott quoted interferences indexes there were no outliers.

The Abbott Index protocol was determined to be accurate and robust
within the limits quoted in the kit inserts and the assays were able to
accommodate a wide range of interferences reliably. There is now no
manual intervention or sample management on the track unless indicated
by the index values. The intervention on samples under the manual
analytical workstations was deemed excessive and wasteful of resource.

 

Cheers,

 

JB 

 

John Blennerhassett

Senior Medical Scientist in Charge

Core Laboratory Biochemistry

Core Clinical Pathology and Biochemistry

PathWest

Royal Perth Hospital

Phone:     +61 (0)8 92241173

Fax:         +61 (0)8 92242492

Mobile:     +61 (0)407771332

email:       [log in to unmask]
<mailto:[log in to unmask]> 

________________________________

From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Maria Fitzgibbon
Sent: Thursday, 5 July 2012 23:45
To: [log in to unmask]
Subject: Attn Abbott users

 

I would be grateful if any Abbott users would be happy to share the
configuration of your lipaemia index with me. Our index differs
significantly in samples with high Tgs for example, Sample 1 had Tg of
39.7mmol/L with a lipaemia index of 9.87, Sample 2 with Tg of
36.73mmol/L had an index of 4.83. We set the lip index at 5 for certain
chemistries and ISEs but I am concerned that since we went to a tracked
system, we are now not detecting samples that would previously have had
further centrifugation and direct ISE measurement.

Many thanks, Maria

 

Dr Maria Fitzgibbon, FRCPath,

Consultant Clinical Biochemist,

Head of Department of Clinical Biochemistry & Diagnostic Endocrinology,
Mater Misericordiae University Hospital, Eccles St, Dublin 7.

Tel:   0035318032423

email: [log in to unmask] 

 

 

 

________________________________

This e-mail and any files transmitted with it contain information which
may be confidential and which may also be privileged and is intended
solely
for the use of the individual or entity to which it is addressed. Unless
you
are the intended recipient you may not copy or use it, or disclose it to
anyone else. Any opinions expressed are that of the individual and not
necessarily that of Mater Misericordiae University Hospital.

------ACB discussion List Information-------- This is an open discussion
list for the academic and clinical community working in clinical
biochemistry. Please note, archived messages are public and can be
viewed via the internet. Views expressed are those of the individual and
they are responsible for all message content. ACB Web Site
http://www.acb.org.uk Green Laboratories Work
http://www.laboratorymedicine.nhs.uk List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions
(How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/